Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells

Published:2013-09 Issue:8 Volume:24 Page:810-817
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Long Qing-Zhi,Zhou Ming,Liu Xiao-Gang,Du Yue-Feng,Fan Jin-Hai,Li Xiang,He Da-Lin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference23 articles.

1. The emerging role of nuclear factor kappa B in renal cell carcinoma.;Morais;Int J Biochem Cell Biol,2011

2. Impact of cisplatin administration on protein expression levels in renal cell carcinoma: a proteomic analysis.;Vasko;Eur J Pharmacol,2011

3. Significance of P-glycoprotein, P53, and survivin expression in renal cell carcinoma.;Baytekin;Int J Cancer,2009

4. Cocktail modulator mixtures for overcoming multidrug resistance in renal cell carcinoma.;Yu;Urology,1999

5. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.;Thiebaut;Proc Natl Acad Sci USA,1987

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the secrets: Evolution of resistance mediated by membrane proteins;Drug Resistance Updates;2024-11

2. Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agents;Expert Opinion on Investigational Drugs;2024-08-11

3. FDA Approval for Phytochemicals in the Treatment of Cancer;Phytonutrients in the Treatment of Gastrointestinal Cancer;2023-04-27

4. The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials;Pharmacological Research;2023-03

5. Advances in Renal Cell Carcinoma Drug Resistance Models;Frontiers in Oncology;2022-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3